Selected manuscripts:

Gavish, R*., Watad, S*., Ben-Califa, N., Goldberg, O. J., Haskin, O., Davidovits, M., Koren, G., Falush, Y., Neumann, D*., and Krause, I*. *equal contribution (2018) Response to erythropoietin in pediatric patients with chronic kidney disease: insights from an in vitro bioassay. Pediatric nephrology 33(11):2123-2129 (2018) [PDF]

Gilboa D., Y. Haim-Ohana, N. Deshet-Unger, N. Ben-Califa, S. Hiram-Bab, D. Reuveni, E. Zigmond, M. Gassmann, Y. Gabet, C. Varol and D. Neumann. Erythropoietin enhances Kupffer cell number and activity in the challenged liver. Sci. Rep. 7(1), 11082-11097 (2017) [PDF]

Deshet-Unger N, Oster HS, Prutchi-Sagiv S, Maaravi N Golishevski N, Neumann D, Mittelman M. Erythropoietin administration is associated with improved T-cell properties in patients with myelodysplastic syndromes. Leuk Res. 2017 Jan;52:20-27. [PDF]

Deshet-Unger N, Hiram-Bab S, Haim-Ohana Y, Mittelman M, Gabet Y, Neumann D. Erythropoietin treatment in murine multiple myeloma: immune gain and bone loss. Sci Rep. 2016 Aug 2;6:30998. [PDF]

Hiram-Bab S, Liron T, Deshet-Unger N, Mittelman M, Gassmann M, Rauner M, Franke K, Wielockx B, Neumann D, Gabet Y. Erythropoietin directly stimulates osteoclast precursors and induces bone loss. FASEB J. 2015 May;29(5):1890-900. [PDF]

Maxwell P, Melendez-Rodríguez F, Matchett KB, Aragones J, Ben-Califa N, Jaekel H, Hengst L, Lindner H, Bernardini A, Brockmeier U, Fandrey J, Grunert F, Oster HS, Mittelman M, El-Tanani M, Thiersch M, Schneider Gasser EM, Gassmann M, Dangoor D, Cuthbert RJ, Irvine A, Jordan A, Lappin T, Thompson J, Neumann D:  Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation. Br J Haematol. 2015 Feb;168(3):429-42.  [PDF] .

Ohana Haim Y., N. Deshet Unger, M. C. Souroujon, M. Mittelman, D. Neumann: Resistance of LPS-activated bone marrow derived macrophages to apoptosis mediated by dexamethasone. Sci. Rep. 4:4323-4333 (2014) [PDF]

Gross M., N. Ben-Califa, M. F. McMullin, M. J. Percy, C. Bento, H. Cario, M. Minkov, D. Neumann:  Polycythemia-inducing mutations in the erythropoietin receptor (EPOR): Mechanism and function as elucidated by epidermal growth factor receptor (EGFR) – EPOR chimeras. Br. J. Haematol. 165(4):519-528 (2014) [PDF]

Reinbothe S., A.M. Larsson, M. Vaapil, C. Wigerup, J. Sun, A. Jögi, D. Neumann, L. Rönnstrand, S. Påhlman: EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation. Biochem. Biophys. Res. Com. 445 (1): 163–169 (2014)  [PDF]

Bento C., M Percy, H. Cario, B. Gardie, T. M. Magalhães, R. van Wijk, S. Perrotta, D. R. Fulvi, H. Almeida, C. Rossi, F. Girodon, M. Åström, D. Neumann, S. Schnittger, B. Landin, M. Minkov, M. L. Randi, S. Rives, L. Ribeiro, S. Hermouet, M. F. McMullin, on behalf of ECE-Consortium: Genetic basis of Congenital Erythrocytosis: mutation update and online databases. Human Mutation, 35 (1):15–26 (2014)  [PDF]

Inbar D., M. Cohen-Armon and D. Neumann: Erythropoietin driven signaling and cell migration mediated by polyADP-ribosylation. Br J Cancer. 107(8):1317-26 (2012). [PDF]

Yosha L, Ravid O, Ben-Califa N, Neumann D: Cytosolic lysine residues enhance anterograde transport and activation of the erythropoietin receptor. The Biochemical journal 2011, 435(2):509-518. [PDF]

Ben-Califa N, Bishara A, Kashman Y, Neumann D: Salarin C, a member of the salarin superfamily of marine compounds, is a potent inducer of apoptosis. Investigational new drugs 2010. [PDF]

Katz O, Stuible M, Golishevski N, Lifshitz L, Tremblay ML, Gassmann M, Mittelman M, Neumann D: Erythropoietin treatment leads to reduced blood glucose levels and body mass: insights from murine models. The Journal of endocrinology 2010, 205(1):87-95. [PDF]

Lifshitz L, Berger A, Mittelman M, Neumann D: Erythropoietin and cyclophosphamide combination treatment additively enhances antibody production in mice. Acta haematologica 2010, 123(2):81-83. [PDF]

Lifshitz L, Tabak G, Gassmann M, Mittelman M, Neumann D: Macrophages as novel target cells for erythropoietin. Haematologica 2010, 95(11):1823-1831. [PDF]

Liron T, Nahari T, Souroujon MC, Neumann D: Insertion of an NPVY sequence into the cytosolic domain of the erythropoietin receptor selectively affects erythropoietin-mediated signalling and function. The Biochemical journal 2010, 427(2):305-312. [PDF]

Avneon M, Lifshitz L, Katz O, Prutchi-Sagiv S, Gassmann M, Mittelman M, Neumann D: Non-erythroid effects of erythropoietin: are neutrophils a target? Leukemia research 2009, 33(10):1430-1432. [PDF]

Bishara A, Rudi A, Goldberg I, Aknin M, Neumann D, Ben-Califa N, Kashman Y: Tausalarin C: a new bioactive marine sponge-derived nitrogenous bismacrolide. Organic letters 2009, 11(16):3538-3541. [PDF]

Lifshitz L, Prutchi-Sagiv S, Avneon M, Gassmann M, Mittelman M, Neumann D: Non-erythroid activities of erythropoietin: Functional effects on murine dendritic cells. Molecular immunology 2009, 46(4):713-721. [PDF]

Bishara A, Rudi A, Aknin M, Neumann D, Ben-Califa N, Kashman Y: Salarins a and B and tulearin a: new cytotoxic sponge-derived macrolides. Organic letters 2008, 10(2):153-156.

Bishara A, Rudi A, Aknin M, Neumann D, Ben-Califa N, Kashman Y: Taumycins A and B, two bioactive lipodepsipeptides from the Madagascar sponge Fascaplysinopsis sp. Organic letters 2008, 10(19):4307-4309. [PDF]

Nahari T, Barzilay E, Hirschberg K, Neumann D: A transplanted NPVY sequence in the cytosolic domain of the erythropoietin receptor enhances maturation. The Biochemical journal 2008, 410(2):409-416. [PDF]

Prutchi Sagiv S, Lifshitz L, Orkin R, Mittelman M, Neumann D: Erythropoietin effects on dendritic cells: potential mediators in its function as an immunomodulator? Experimental hematology 2008, 36(12):1682-1690. [PDF]

Ghezzi P, Mengozzi M: Activities of erythropoietin on tumors: an immunological perspective. European journal of immunology 2007, 37(6):1427-1430.

Katz O, Gil L, Lifshitz L, Prutchi-Sagiv S, Gassmann M, Mittelman M, Neumann D: Erythropoietin enhances immune responses in mice. European journal of immunology 2007, 37(6):1584-1593. [PDF]

Ravid O, Shams I, Ben Califa N, Nevo E, Avivi A, Neumann D: An extracellular region of the erythropoietin receptor of the subterranean blind mole rat Spalax enhances receptor maturation. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(36):14360-14365. [PDF]

Sorek H, Rudi A, Benayahu Y, Ben-Califa N, Neumann D, Kashman Y: Nuttingins A-F and malonganenones D-H, tetraprenylated alkaloids from the Tanzanian gorgonian Euplexaura nuttingi. Journal of natural products 2007, 70(7):1104-1109. [PDF]

Katz O, Barzilay E, Skaat A, Herman A, Mittelman M, Neumann D: Erythropoietin induced tumour mass reduction in murine lymphoproliferative models. Acta haematologica 2005, 114(3):177-179. [PDF]

Mittelman M, Zeidman A, Kanter P, Katz O, Oster H, Rund D, Neumann D: Erythropoietin has an anti-myeloma effect – a hypothesis based on a clinical observation supported by animal studies. European journal of haematology 2004, 72(3):155-165. [PDF]